查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561601

2024-2032 年按产品、应用、组织类型和地区分類的组织银行市场报告

Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球组织库IMARC Group规模达到 18 亿美元。新兴的研发（R＆D）投资、冷冻保存的进步、慢性病和遗传性疾病的增加、对个人化医疗的需求不断增长、基因组学的改进、监管的进步、战略合作以及研究人员意识的增强是推动这一趋势的一些因素。

组织银行市场分析：

  • 主要市场驱动因素：再生医学的快速进步和器官移植手术的日益普及推动了全球组织库市场的发展。政府采取的越来越多的倡议以及人们对组织捐赠的认识不断提高是预计推动市场成长的其他因素。此外，人们越来越关注开发更可行且保质期更长的组织保存和储存技术，这是市场的另一个成长诱导因素。随着慢性病和创伤病例的增加，组织库的需求呈指数级增长，这是刺激市场成长的另一个因素。除此之外，扩大医疗基础设施，特别是在发展中国家，正在促进市场成长。其他因素，例如对生物库和个人化医疗的投资增加以及研究机构和组织库之间的合作不断升级，正在促进市场成长。
  • 主要市场趋势：自动化组织处理和保存系统的发展是主要市场趋势之一，它有助于最大限度地减少处理过程所需的时间，并减少人为错误。在组织银行中不断使用人工智慧 (AI) 和机器学习 (ML) 来改善资料管理，为市场成长创造了积极的前景。与此一致的是，严格的道德法规迫使纸巾烘焙企业标准化其运营，这进一步推动了市场的成长。此外，生物製药公司和组织库之间不断升级的合作以及对冷冻保存方法的日益关注正在推动市场的成长。
  • 地理趋势：北美在全球组织银行市场中占据领先份额，因为它拥有强大的医疗基础设施、更高的组织捐赠意识以及对医学研究的大量投资。该地区的主导地位也归功于主要市场参与者的强大存在和先进的技术能力。有利的政府环境和健全的公共卫生系统推动了欧洲市场的成长。亚太地区的组织库市场受到不断增长的医疗保健支出、不断扩大的生物库计划以及不断增长的组织移植数量的推动。
  • 竞争格局：组织库产业的一些主要市场参与者包括 AMS Biotechnology、Beckman Coulter Inc.（Danaher Corporation）、Bio-Rad Laboratories Inc.、Brooks Life Sciences Inc.（Brooks Automation Inc.）、Eppendorf AG、Merck KGaA、 PHC Corporation、QIAGEN NV、Sartorius AG、Taylor-Wharton、Thermo Fisher Scientific Inc.、VWR International LLC (Avantor Inc) 等。
  • 挑战与机会：为市场带来挑战的因素包括严格的监管要求、组织捐赠和处理的道德问题以及复杂储存方法的高成本。储存组织的品质和安全无疑是首要关注的问题，这需要遵守严格的标准。由于意识水平低和文化障碍，一些地区的组织捐赠率有限。然而，它们也为市场发展提供了各种机会，例如由于公众意识和教育的迅速发展而导致组织捐赠率不断增加。负担能力是保存技术和储存解决方案提供者可以考虑解决的另一个因素。

组织银行市场趋势：

增加研发投资

全球组织库市场的成长主要是由研发投资的增加所推动的，特别是在再生医学和个人化治疗方面。随着科学界和医学界对疾病认识和治疗的进步，组织样本捐赠显着增长，这进一步推动了市场的成长。这些样本对于了解疾病的生物学、测试新药在患者中的潜在用途以及确定可能受益于特定药物的患者群体至关重要。随着干细胞治疗和基因编辑等领域的研究取得进展，它增加了对特定组织样本的依赖，进一步增加了对每个人都可以存取的保存完好的组织库的需求。例如，最近，加州大学旧金山分校推出了世界上第一个组织库，其中包含长期新冠患者捐赠的样本。先前的研究表明，这种病毒可以继续在全身徘徊，可能是了解这种使人衰弱的疾病的原因并找到有效治疗方法的关键。

低温保存技术的进步

低温保存技术的发展是推动全球组织库市场的主要因素之一。冷冻保存是在冰点以下储存活体组织和细胞并保持其活力的有效方法。快速发展的技术加速了这个过程，使保存组织的品质及其耐用性变得更好。此外，还开发了新的冷冻保护剂和冷却技术，例如防止冰晶形成的玻璃化，否则会损坏细胞结构。此外，冷冻保存的自动化进一步实现了操作自动化，有助于最大限度地减少人为错误并提高吞吐量，从而促进了市场的成长。

慢性病和遗传性疾病的盛行率不断上升

遗传疾病和慢性病发病率的不断上升是加速全球组织库市场发展的主要因素之一。根据对沙乌地阿拉伯人口进行的全国调查，成年男性和女性的糖尿病（DM）盛行率估计为男性14.8%，而女性则较低，为11.7%。癌症、心血管疾病和糖尿病等慢性疾病需要广泛的研究来了解其病理生理学并开发有效的治疗方法。组织库透过提供多种生物样本为这项研究提供关键资源，这对于研究疾病机制、开发新药和测试治疗效果至关重要。

组织银行市场区隔：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、应用和纸巾类型对市场进行了分类。

按产品划分：

  • 装置
    • 冷冻保存设备
    • 解冻设备
    • 品质管制设备
    • 其他的
  • 介质和耗材

设备占大部分市场份额

该报告根据产品提供了详细的市场细分和分析。这包括设备（冷冻保存设备、解冻设备、品质控制设备等）以及介质和消耗品。报告称，设备占最大部分。

对先进可靠的组织保存和分析系统的需求不断增长，推动了设备领域的发展。自动化和改进的冷冻保存技术等技术进步对于提高组织处理和储存的效率和准确性至关重要。研究活动和临床试验的增加需要最先进的设备来确保高品质和可重复的结果。此外，对个人化医疗和再生疗法的日益关注推动了对能够管理多样化和复杂组织样本的专用设备的需求。品质和安全标准的监管要求进一步推动了精密设备的采用。对医疗保健基础设施的投资增加和全球组织库的扩张也促进了对先进设备的需求。

按应用划分：

  • 疗法
  • 医学研究
  • 其他的

治疗药物占业界最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括治疗、医学研究等。报告称，治疗药物占据最大的市场份额。

治疗领域受到对个人化医疗日益增长的需求的推动，这需要使用特定的、高品质的组织样本来根据个别基因图谱量身定制治疗方案。基因组学和生物技术的进步进一步推动了这种成长，因为它们使研究人员和临床医生能够更好地了解复杂的疾病机制并开发有针对性的疗法。此外，慢性病和遗传性疾病盛行率的上升加速了对创新治疗解决方案的需求，导致研发活动激增。药物发现的技术进步，包括高通量筛选和复杂的生物资讯工具，也至关重要，因为它们依赖多样化且特征良好的生物样本来识别和验证新的治疗标靶。人们对再生医学和细胞疗法（例如干细胞治疗和组织工程）的日益重视，推动了对强大的组织库基础设施的需求，而组织库基础设施为这些尖端疗法提供了必要的材料。

按组织类型划分：

  • 心血管组织
  • 肺组织
  • 肾臟组织
  • 胰臟组织
  • 肝臟组织
  • 眼组织
  • 其他的

心血管组织代表领先的细分市场

该报告根据卫生纸类型提供了详细的市场细分和分析。这包括心血管组织、肺组织、肾臟组织、胰臟组织、肝臟组织、眼部组织等。根据该报告，心血管组织占最大部分。

心血管组织领域是由心血管疾病（CVD）盛行率不断上升所驱动的，心血管疾病是全球死亡的主要原因之一。 CVD病例的激增需要广泛的研究和开发工作，从而刺激了对高品质心血管组织的需求，以用于研究疾病机制、开发创新疗法和测试治疗干预措施。组织工程和再生医学的进步也至关重要，因为它们使得心血管组织的创建和使用能够用于开发个人化疗法和改善患者的治疗结果。对个人化医疗的日益重视进一步推动了需求，因为临床医生寻求与患者个人资料相符的组织样本，以製定更有效的治疗计划。此外，生物样本库技术的不断进步，包括改进的保存方法和更好的组织表征技术，提高了心血管组织的品质和可用性。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场领先，占据最大的组织银行市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。根据该报告，北美是组织银行最大的区域市场。

北美区域市场受到医疗保健研究和生物技术投资不断增加的推动，这大大增加了对高品质组织样本的需求。该地区先进的研究机构和强大的製药业的存在加速了对维护良好的组织库的需求，以支持再生医学、个人化治疗和药物开发的创新研究。此外，北美慢性病和遗传性疾病的日益普及推动了对不同组织样本的需求，以了解疾病机制并开发有效的治疗方法。冷冻保存和组织储存的技术进步进一步增强了市场，提供了延长保存组织活力并提高整体研究品质的解决方案。北美的监管环境也发挥着至关重要的作用；严格的标准和准则确保组织库实践的品质和安全，从而增强组织库的信任和可靠性。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

  • 组织库市场的主要参与者正在积极参与各种策略性倡议，以增强其市场地位并推动创新。领先公司正在大力投资研发，以推动冷冻保存技术、改进组织储存方法并开发组织样本的新应用。这包括实施尖端的自动化和数位解决方案，以简化操作、提高效率并确保生物材料的高品质保存。此外，这些参与者还透过建立新的组织库并与学术机构、生物製药公司和医疗保健组织建立策略性合作伙伴关係来扩大其全球足迹。为了满足对专业且特征明确的组织标本不断增长的需求，主要参与者也致力于使其组织收藏多样化并结合先进的基因组和分子表征技术。此外，遵守法规和建立严格的品质控制标准是首要任务，确保其实践符合国际准则并提高组织资源的可靠性。

组织银行市场新闻：

  • 2023 年，美国组织库协会 (AATB) 启动了一项重大项目，旨在修订和简化其组织库标准。该项目涉及与各个利益相关者的广泛合作，以确保新标准易于使用且全面。
  • 2022 年 11 月，阿布达比健康部与总部位于美国的非营利性眼库 Eversight 合作推出了阿联酋首家眼科和组织库。

本报告回答的关键问题

  • 2023 年全球组织库市场规模有多大
  • 2024-2032年全球组织库市场的预期成长率是多少
  • 推动全球组织银行市场的关键因素是什么
  • COVID-19 对全球组织库市场有何影响
  • 基于产品的全球组织银行市场的细分是什么
  • 基于应用程式的全球组织银行市场的细分是什么
  • 根据组织类型，全球组织银行市场的细分如何
  • 全球组织库市场的关键区域有哪些
  • 谁是全球组织银行市场的主要参与者/公司

本报告回答的关键问题

  • 2023 年全球组织库市场规模有多大？ 2024-2032 年全球组织库市场的预期成长率是多少？
  • 推动全球组织银行市场的关键因素是什么？
  • COVID-19 对全球组织库市场有何影响？
  • 基于该产品的全球组织银行市场的细分情况如何？
  • 基于应用程式的全球组织银行市场的细分是什么？
  • 根据组织类型，全球组织银行市场的细分如何？
  • 全球组织库市场的关键区域有哪些？
  • 谁是全球组织银行市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球组织库市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 装置
    • 市场趋势
    • 关键环节
      • 超低温保存设备
      • 解冻设备
      • 品质管制设备
      • 其他的
    • 市场预测
  • 介质和耗材
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 疗法
    • 市场趋势
    • 市场预测
  • 医学研究
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依组织类型

  • 心血管组织
    • 市场趋势
    • 市场预测
  • 肺组织
    • 市场趋势
    • 市场预测
  • 肾臟组织
    • 市场趋势
    • 市场预测
  • 胰臟组织
    • 市场趋势
    • 市场预测
  • 肝臟组织
    • 市场趋势
    • 市场预测
  • 眼组织
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AMS Biotechnology
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • Brooks Life Sciences Inc. (Brooks Automation Inc.)
    • Eppendorf AG
    • Merck KGaA
    • PHC Corporation
    • QIAGEN NV
    • Sartorius AG
    • Taylor-Wharton
    • Thermo Fisher Scientific Inc.
    • VWR International LLC (Avantor Inc)
Product Code: SR112024A4764

The global tissue banking market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032. The burgeoning research and development (R&D) investments, advancements in cryopreservation, the rise in chronic diseases and genetic disorders, growing demand for personalized medicine, improvements in genomics, regulatory advancements, strategic collaborations, and enhanced awareness among researchers are some of the factors boosting the market growth.

Tissue Banking Market Analysis:

  • Major Market Drivers: The global market for tissue banking is driven by the expediating progress in regenerative medicine and growing adoption of organ transplantation procedures. Increasing number of initiatives undertaken by the government and rising awareness regarding tissue donation are other factors expected to drive the market growth. Moreover, surging focus on the development of tissue preservation and storage techniques that are more viable and offer longer shelf life is another growth-inducing factor for the market. With the increasing rate of chronic diseases and trauma cases, the demand for tissue banking is growing exponentially, which is another factor stimulating the market growth. Apart from this, expanding healthcare infrastructure especially in developing countries is facilitating the market growth. Other factors, such as mounting investments into biobanking and personalized medicine and escalating collaborations among research institutions and tissue banks, are promoting the market growth.
  • Key Market Trends: The development of automated tissue processing and preservation systems, which has helped minimize the amount of time taken to do a process with reduced human error, is one of the primary market trends. The escalating use of artificial intelligence (AI) and machine learning (ML) in tissue banking to improve data management is creating a positive outlook for the market growth. In line with this, stringent ethical regulations has compelled the tissue baking players to standardize their operations, which is further fueling the market growth. Moreover, the escalating collaboration between biopharmaceutical companies and tissue banks and surging attention on the cryopreservation methods are propelling the market growth.
  • Geographical Trends: North America holds a leading share in the global tissue banking market as it is backed by a strong healthcare infrastructure, higher awareness about tissue donation, and significant investments in medical research. The region's dominance is also due to the strong presence of key market players and advanced technological capabilities. Europe's market growth is propelled by favorable governmental contexts and robust public health systems. Asia-Pacific's tissue banking market is bolstered by the burgeoning healthcare expenditure, expanding biobanking initiatives, and growing number of tissue transplantation.
  • Competitive Landscape: Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), among many others.
  • Challenges and Opportunities: The factors creating challenges for the market include stringent regulatory requirements, ethical issues about tissue donation and processing, and the high costs of sophisticated storage methods. The quality and safety of stored tissues is aptly the primary concern, which entails adherence to stringent standards. Tissue donation rates are limited in some parts due to low level of awareness and cultural barriers. However, they also offer various opportunities for market development, such as the increasing tissue donation rates due to burgeoning public awareness and education. Affordability is another factor that preservation technology and storage solution providers can consider to address.

Tissue Banking Market Trends:

Increasing Investments in Research and Development

The global tissue banking market is predominantly driven in growth by the increasing investment in R&D, especially for regenerative medicine and personalized therapies. With the advancements in disease understanding and treatment by scientific and medical communities, there is a significant growth in tissue sample donations, which is further fueling the market growth. These samples are key to understanding the biology of disease, testing new drugs for potential use in patients, and identifying patient populations that may benefit from a particular drug. As research progresses in fields such as stem cell therapy and gene editing, it thrusts the reliance on specific tissue samples, further increasing the demand for well-preserved banks of tissues accessible by everyone. For instance, recently, UC San Francisco launched the world's first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments.

Advances in Cryopreservation Technologies

The development of cryopreservation technologies is one of the major factors which is pushing the global tissue banking market. Cryopreservation is an effective way to store living tissue and cells below freezing temperatures while keeping it viable. Rapidly advancing technologies have accelerated this process, making the quality of preserved tissues and their durability much better. Additionally, new cryoprotectants and cooling techniques are developed, such as vitrification that prevents ice crystal formation, which can otherwise damage cell structures. Moreover, automation in cryopreservation further automates the operations and helps in minimizing human error and increasing throughput, which is bolstering the market growth.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing incidence of genetic diseases and chronic conditions is one of the primary factor accelerating the global tissue banking market. As per the national survey carried out in Saudi population, Diabetes Mellitus (DM) among adult males and females were estimated with prevalence rates 14.8% for male, while it was lower for female group where 11.7%. Chronic conditions such as cancer, cardiovascular diseases, and diabetes require extensive research to understand their pathophysiology and develop effective treatments. Tissue banks provide critical resources for this research by offering a diverse array of biological samples, which are essential for studying disease mechanisms, developing new drugs, and testing treatment efficacy.

Tissue Banking Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and tissue type.

Breakup by Product:

  • Equipment
    • Cryopreservation Equipment
    • Thawing Equipment
    • Quality Control Equipment
    • Others
  • Media and Consumables

Equipment accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes equipment (cryopreservation equipment, thawing equipment, quality control equipment, others) and media and consumables. According to the report, equipment represented the largest segment.

The equipment segment is driven by the increasing demand for advanced and reliable systems for tissue preservation and analysis. Technological advancements, such as automation and improved cryopreservation techniques, are crucial in enhancing the efficiency and accuracy of tissue handling and storage. The rise in research activities and clinical trials necessitates state-of-the-art equipment to ensure high-quality and reproducible results. Additionally, the growing focus on personalized medicine and regenerative therapies fuels the need for specialized equipment capable of managing diverse and complex tissue samples. Regulatory requirements for quality and safety standards further drive the adoption of sophisticated equipment. Increased investments in healthcare infrastructure and the expansion of tissue banks globally also contribute to the demand for advanced equipment.

Breakup by Application:

  • Therapeutics
  • Medical Research
  • Others

Therapeutics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes therapeutics, medical research, and others. According to the report, therapeutics accounted for the largest market share.

The therapeutics segment is driven by the increasing demand for personalized medicine, which necessitates the use of specific, high-quality tissue samples to tailor treatments to individual genetic profiles. Advances in genomics and biotechnology further fuel this growth, as they enable researchers and clinicians to better understand complex disease mechanisms and develop targeted therapies. Additionally, the rising prevalence of chronic diseases and genetic disorders accelerates the need for innovative therapeutic solutions, leading to a surge in research and development activities. Technological advancements in drug discovery, including high-throughput screening and sophisticated bioinformatics tools, are also pivotal, as they rely on diverse and well-characterized biological samples to identify and validate new therapeutic targets. The growing emphasis on regenerative medicine and cell therapies, such as stem cell treatments and tissue engineering, drives demand for robust tissue banking infrastructure, which provides essential materials for these cutting-edge therapies.

Breakup by Tissue Type:

  • Cardiovascular Tissue
  • Lung Tissue
  • Kidney Tissue
  • Pancreas Tissue
  • Liver Tissue
  • Eye Tissue
  • Others

Cardiovascular Tissue represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the tissue type. This includes cardiovascular tissue, lung tissue, kidney tissue, pancreas tissue, liver tissue, eye tissue, and others. According to the report, cardiovascular tissue represented the largest segment.

The cardiovascular tissue segment is driven by the increasing prevalence of cardiovascular diseases (CVDs), which are among the leading causes of mortality globally. This surge in CVD cases necessitates extensive research and development efforts, fueling the demand for high-quality cardiovascular tissues for studying disease mechanisms, developing innovative treatments, and testing therapeutic interventions. Advances in tissue engineering and regenerative medicine are also pivotal, as they enable the creation and use of cardiovascular tissues for developing personalized therapies and improving patient outcomes. The growing emphasis on personalized medicine further drives demand, as clinicians seek tissue samples that match individual patient profiles for more effective treatment plans. Additionally, ongoing advancements in biobanking technologies, including improved preservation methods and better tissue characterization techniques, enhance the quality and availability of cardiovascular tissues.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest tissue banking market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for tissue banking.

The North America regional market is driven by the increasing investments in healthcare research and biotechnology, which significantly bolster the demand for high-quality tissue samples. The presence of advanced research institutions and a robust pharmaceutical industry in the region accelerates the need for well-maintained tissue banks to support innovative studies in regenerative medicine, personalized therapies, and drug development. Additionally, the growing prevalence of chronic diseases and genetic disorders in North America drives the need for diverse tissue samples to understand disease mechanisms and develop effective treatments. Technological advancements in cryopreservation and tissue storage further enhance the market, providing solutions that extend the viability of preserved tissues and improve overall research quality. The regulatory landscape in North America also plays a crucial role; stringent standards and guidelines ensure the quality and safety of tissue banking practices, which in turn fosters trust and reliability in tissue banks.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • Key players in the tissue banking market are actively engaged in a variety of strategic initiatives to enhance their market position and drive innovation. Leading companies are investing heavily in R&D to advance cryopreservation technologies, improve tissue storage methods, and develop new applications for tissue samples. This includes implementing cutting-edge automation and digital solutions to streamline operations, increase efficiency, and ensure high-quality preservation of biological materials. Additionally, these players are expanding their global footprint by establishing new tissue banks and forming strategic partnerships with academic institutions, biopharmaceutical companies, and healthcare organizations. To address the growing demand for specialized and well-characterized tissue specimens, key players are also focusing on diversifying their tissue collections and incorporating advanced genomic and molecular characterization techniques. Moreover, regulatory compliance and the establishment of rigorous quality control standards are priorities, ensuring that their practices meet international guidelines and enhance the reliability of tissue resources.

Tissue Banking Market News:

  • In 2023, The American Association of Tissue Banks (AATB) has initiated a significant project aimed at revising and streamlining its Standards for Tissue Banking. This project involves extensive collaboration with various stakeholders to ensure the new standards are user-friendly and comprehensive.
  • In November 2022, Abu Dhabi's Department of Health and Eversight, a U.S.-based non-profit eye bank, collaborated to launch the UAE's inaugural Eye and Tissue Bank.

Key Questions Answered in This Report

  • 1. What was the size of the global tissue banking market in 2023?
  • 2. What is the expected growth rate of the global tissue banking market during 2024-2032?
  • 3. What are the key factors driving the global tissue banking market?
  • 4. What has been the impact of COVID-19 on the global tissue banking market?
  • 5. What is the breakup of the global tissue banking market based on the product?
  • 6. What is the breakup of the global tissue banking market based on the application?
  • 7. What is the breakup of the global tissue banking market based on the tissue type?
  • 8. What are the key regions in the global tissue banking market?
  • 9. Who are the key players/companies in the global tissue banking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Cryopreservation Equipment
      • 6.1.2.2 Thawing Equipment
      • 6.1.2.3 Quality Control Equipment
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Media and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Tissue Type

  • 8.1 Cardiovascular Tissue
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Tissue
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Kidney Tissue
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pancreas Tissue
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Tissue
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Eye Tissue
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AMS Biotechnology
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Eppendorf AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PHC Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 QIAGEN N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Taylor-Wharton
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 VWR International LLC (Avantor Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Tissue Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Banking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tissue Banking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Tissue Banking Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Tissue Banking Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Tissue Banking Market: Breakup by Tissue Type (in %), 2023
  • Figure 7: Global: Tissue Banking Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Tissue Banking (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Tissue Banking (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Tissue Banking (Media and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Tissue Banking (Media and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Tissue Banking (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tissue Banking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tissue Banking (Medical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tissue Banking (Medical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tissue Banking (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tissue Banking (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tissue Banking (Cardiovascular Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tissue Banking (Cardiovascular Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tissue Banking (Lung Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tissue Banking (Lung Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tissue Banking (Kidney Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tissue Banking (Kidney Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tissue Banking (Pancreas Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tissue Banking (Pancreas Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tissue Banking (Liver Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tissue Banking (Liver Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tissue Banking (Eye Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tissue Banking (Eye Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Tissue Banking (Other Tissue Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Tissue Banking (Other Tissue Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Tissue Banking Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Tissue Banking Industry: SWOT Analysis
  • Figure 82: Global: Tissue Banking Industry: Value Chain Analysis
  • Figure 83: Global: Tissue Banking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tissue Banking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tissue Banking Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Tissue Banking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Tissue Banking Market Forecast: Breakup by Tissue Type (in Million US$), 2024-2032
  • Table 5: Global: Tissue Banking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Tissue Banking Market: Competitive Structure
  • Table 7: Global: Tissue Banking Market: Key Players